Colgate-Palmolive (NYSE:CL) Shares Purchased by Sumitomo Mitsui Trust Group Inc.

Sumitomo Mitsui Trust Group Inc. lifted its stake in shares of Colgate-Palmolive (NYSE:CL - Free Report) by 1.2% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,989,776 shares of the company's stock after acquiring an additional 23,099 shares during the quarter. Sumitomo Mitsui Trust Group Inc. owned approximately 0.24% of Colgate-Palmolive worth $206,559,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in CL. E Fund Management Hong Kong Co. Ltd. purchased a new stake in shares of Colgate-Palmolive during the second quarter worth about $25,000. Continuum Advisory LLC boosted its stake in Colgate-Palmolive by 46.5% in the 2nd quarter. Continuum Advisory LLC now owns 394 shares of the company's stock worth $38,000 after purchasing an additional 125 shares during the period. Reston Wealth Management LLC purchased a new stake in Colgate-Palmolive during the 3rd quarter valued at approximately $42,000. Capital Performance Advisors LLP bought a new stake in shares of Colgate-Palmolive during the third quarter valued at approximately $53,000. Finally, Gradient Investments LLC lifted its holdings in shares of Colgate-Palmolive by 150.4% in the second quarter. Gradient Investments LLC now owns 666 shares of the company's stock worth $65,000 after buying an additional 400 shares in the last quarter. Institutional investors own 80.41% of the company's stock.

Colgate-Palmolive Stock Down 0.5 %

Shares of CL stock traded down $0.42 on Wednesday, hitting $91.08. The stock had a trading volume of 3,456,104 shares, compared to its average volume of 4,372,999. Colgate-Palmolive has a one year low of $75.17 and a one year high of $109.30. The business has a 50 day moving average price of $100.30 and a 200 day moving average price of $98.53. The company has a market cap of $74.41 billion, a PE ratio of 26.13, a P/E/G ratio of 3.27 and a beta of 0.42. The company has a quick ratio of 0.68, a current ratio of 1.04 and a debt-to-equity ratio of 9.46.

Colgate-Palmolive Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, October 18th will be issued a $0.50 dividend. The ex-dividend date is Friday, October 18th. This represents a $2.00 annualized dividend and a dividend yield of 2.20%. Colgate-Palmolive's dividend payout ratio is currently 57.31%.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on CL. Evercore ISI lifted their price target on shares of Colgate-Palmolive from $100.00 to $106.00 and gave the company an "outperform" rating in a report on Thursday, July 18th. UBS Group lifted their target price on Colgate-Palmolive from $119.00 to $122.00 and gave the stock a "buy" rating in a report on Wednesday, September 4th. Sanford C. Bernstein boosted their target price on Colgate-Palmolive from $100.00 to $103.00 and gave the stock a "market perform" rating in a research report on Tuesday, July 30th. JPMorgan Chase & Co. raised their price target on Colgate-Palmolive from $113.00 to $114.00 and gave the company an "overweight" rating in a report on Friday, October 11th. Finally, TD Cowen decreased their price objective on Colgate-Palmolive from $115.00 to $110.00 and set a "buy" rating on the stock in a report on Monday, October 28th. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating and thirteen have given a buy rating to the stock. According to data from MarketBeat, Colgate-Palmolive currently has an average rating of "Moderate Buy" and a consensus price target of $105.11.

Insider Transactions at Colgate-Palmolive

In related news, Director Martina Hundmejean sold 2,313 shares of Colgate-Palmolive stock in a transaction that occurred on Friday, August 23rd. The shares were sold at an average price of $103.86, for a total transaction of $240,228.18. Following the transaction, the director now directly owns 11,755 shares of the company's stock, valued at $1,220,874.30. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. In related news, Director Martina Hundmejean sold 2,313 shares of the company's stock in a transaction on Friday, August 23rd. The stock was sold at an average price of $103.86, for a total transaction of $240,228.18. Following the completion of the sale, the director now directly owns 11,755 shares in the company, valued at $1,220,874.30. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, CFO Stanley J. Sutula III sold 45,410 shares of Colgate-Palmolive stock in a transaction that occurred on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the completion of the transaction, the chief financial officer now directly owns 36,726 shares in the company, valued at approximately $3,456,283.86. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 0.34% of the company's stock.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.